Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | GSK2334470 | 0.0316227766017 | -0.5843 | -0.21683 |
| HCC1500 | Rucaparib | 0.0316227766017 | 1.2436 | -0.21649 |
| HCC1500 | SHP099 | 0.01 | 0.7505 | -0.21631 |
| HCC1500 | SHP099 | 0.316227766017 | 1.4958 | -0.21535 |
| HCC1500 | BMS-265246 | 0.316227766017 | 1.0742 | -0.21515 |
| HCC1500 | THZ531 | 0.0316227766017 | -0.5791 | -0.21452 |
| HCC1500 | SHP099 | 0.1 | 0.8781 | -0.21445 |
| HCC1500 | AZD5363 | 0.01 | 1.4958 | -0.21145 |
| HCC1500 | Alvocidib | 0.0001 | 1.3101 | -0.21107 |
| HCC1500 | Alvocidib | 0.01 | -0.0073 | -0.21072 |
| HCC1500 | THZ531 | 0.01 | 0.0036 | -0.20981 |
| HCC1500 | AZD6738 | 10.0 | -0.7440 | -0.20968 |
| HCC1500 | MK 1775 | 0.01 | 0.7683 | -0.20933 |
| HCC1500 | RO-3306 | 1.0 | -0.2903 | -0.20928 |
| HCC1500 | Ribociclib | 10.0 | 1.0336 | -0.20881 |
| HCC1500 | Senexin B | 0.01 | 0.9352 | -0.20792 |
| HCC1500 | THZ1 | 0.01 | 1.0136 | -0.20764 |
| HCC1500 | SHP099 | 0.00316227766017 | -0.1009 | -0.20674 |
| HCC1500 | BMS-265246 | 0.316227766017 | 0.5975 | -0.20649 |
| HCC1500 | AZD6738 | 0.316227766017 | 0.4114 | -0.20631 |
| HCC1500 | AZD6738 | 0.00316227766017 | 2.1613 | -0.20617 |
| HCC1500 | Senexin B | 0.00316227766017 | 0.0369 | -0.20603 |
| HCC1500 | Ribociclib | 0.01 | -0.5686 | -0.20506 |
| HCC1500 | GSK2334470 | 0.00316227766017 | -0.4174 | -0.20456 |
| HCC1500 | THZ1 | 0.0316227766017 | -0.3064 | -0.20428 |